Bradykinin-induced knee joint incapacitation involves bradykinin B 2 receptor mediated hyperalgesia and bradykinin B 1 receptor-mediated nociception

By Tonussi C.R.   Ferreira S.H.  

European Journal of Pharmacology, Vol. 326, Iss. 1, 1997-05 ,pp. : 61-65

Elsevier

Access to resources Recommend Favorite

Icatibant, the bradykinin B2 receptor antagonist with target to the interconnected kinin systems

By Charignon Delphine   Späth Peter   Martin Ludovic   Drouet Christian  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 15, 2012-10 ,pp. : 2233-2247

Informa Healthcare

Access to resources Recommend Favorite

Characterization of bradykinin B 2 receptor antagonists in human and rat urinary bladder

By Meini S.   Patacchini R.   Giuliani S.   Lazzeri M.   Turini D.   Maggi C.A.   Lecci A.  

European Journal of Pharmacology, Vol. 388, Iss. 2, 2000-01 ,pp. : 177-182

Elsevier

Access to resources Recommend Favorite

The therapeutic potential of bradykinin B2 receptor agonists in the treatment of cardiovascular disease

By Heitsch Holger  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 5, 2003-05 ,pp. : 759-770

Informa Healthcare

Access to resources Recommend Favorite

Non-peptide Antagonists and Agonists of the Bradykinin B2 Receptor

By  

Current Medicinal Chemistry, Vol. 9, Iss. 9, 2002-05 ,pp. : 913-928

Bentham Science Publishers

Access to resources Recommend Favorite